Limited sampling strategy using Bayesian estimation for estimating individual exposure of the once-daily prolonged-release formulation of tacrolimus in kidney transplant children
暂无分享,去创建一个
[1] G. Deschênes,et al. Population pharmacokinetics and pharmacogenetics of once daily prolonged-release formulation of tacrolimus in pediatric and adolescent kidney transplant recipients , 2013, European Journal of Clinical Pharmacology.
[2] G. Deschênes,et al. Limited Sampling Strategy for Estimating Individual Exposure of Tacrolimus in Pediatric Kidney Transplant Patients , 2011, Therapeutic drug monitoring.
[3] F. Alvarez,et al. Limited Sampling Strategies for Monitoring Tacrolimus in Pediatric Liver Transplant Recipients , 2011, Therapeutic drug monitoring.
[4] Cees Neef,et al. Optimal Sampling Strategy Development Methodology Using Maximum A Posteriori Bayesian Estimation , 2011, Therapeutic drug monitoring.
[5] M. Fakhoury,et al. Developmental Pharmacogenetics of Immunosuppressants in Pediatric Organ Transplantation , 2010, Therapeutic drug monitoring.
[6] A. Prémaud,et al. Population Pharmacokinetics and Bayesian Estimation of Tacrolimus Exposure in Renal Transplant Recipients on a New Once-Daily Formulation , 2010, Clinical pharmacokinetics.
[7] P. Marquet,et al. Pharmacokinetic Modeling and Development of Bayesian Estimators in Kidney Transplant Patients Receiving the Tacrolimus Once-Daily Formulation , 2010, Therapeutic drug monitoring.
[8] A. Bensman,et al. Population Pharmacokinetics and Pharmacogenetics of Tacrolimus in De Novo Pediatric Kidney Transplant Recipients , 2009, Clinical pharmacology and therapeutics.
[9] M. First. First Clinical Experience With the New Once-Daily Formulation of Tacrolimus , 2008, Therapeutic drug monitoring.
[10] J H Proost,et al. Validation of limited sampling models (LSM) for estimating AUC in therapeutic drug monitoring--is a separate validation group required? , 2007, International journal of clinical pharmacology and therapeutics.
[11] M. Pescovitz,et al. Once‐Daily Tacrolimus Extended‐Release Formulation: 1‐Year Post‐Conversion in Stable Pediatric Liver Transplant Recipients , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.
[12] Mary H. H. Ensom,et al. Beyond Cyclosporine: A Systematic Review of Limited Sampling Strategies for Other Immunosuppressants , 2006, Therapeutic drug monitoring.
[13] G. Filler,et al. Universal approach to pharmacokinetic monitoring of immunosuppressive agents in children , 2002, Pediatric transplantation.